CVR Medical Logo
CA1266321084
A2ASKP
CRRVF

CVR Medical

Kurser indlæses...

Prognose

Vi har ingen analytikerdata for denne virksomhed.

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • CVR Energy misses Q1 2026 forecasts significantly and reports large net loss

    CVR Energy reported Q1 2026 EPS of -1.24 USD, well below the expected -0.38 USD, while revenue of 1.98 billion USD exceeded estimates. The company recorded a consolidated net loss of 160 million USD and adjusted EBITDA of 37 million USD. Results were hurt by unrealized losses on derivative transactions and high RIN prices; the stock fell 1.58% in premarket trading. For Q2 2026 CVR expects throughput of 200,000–215,000 bpd and direct operating costs of 110–120 million USD; strategic adjustments to the crude slate are intended to improve margins. » Mere på de.investing.com


  • CVR Energy hits 52-week high and offers high dividend yield

    CVR Energy’s stock rose to $33.25, marking a 52-week high and bringing market capitalization to about $3.33 billion. The yield is 11.49% and the company has paid dividends for 12 consecutive years. Despite a strong price gain of 39.4% over the past year (58.45% in six months), CVR reported an adjusted loss per share of $0.23 in Q2/2025 (expectation: -$0.06), but beat revenue expectations with $1.76 billion. Analyst notes indicate the stock may be trading above its fair value; gross profit margin remained weak at 1.63%. » Mere på de.investing.com


  • CVR Energy reaches 52-week high at 32.67 USD

    CVR Energy’s stock rose to a 52-week high of 32.67 USD and has gained 70.7% over the past six months; year-to-date the increase is 49.4%. InvestingPro cites a dividend yield of 11.35% and notes 12 consecutive years of dividend payments, but considers the stock to be above its fair value. For Q2 2025 the company reported an adjusted loss per share of 0.23 USD (expectation: -0.06 USD) on revenue of 1.76 billion USD (expectation: 1.68 billion USD), after which the stock fell sharply in after-hours trading. » Mere på de.investing.com


  • CVRx increases revenue but misses earnings forecast in second quarter 2025

    CVRx grew its revenue by 15% to $13.6 million in the second quarter of 2025, surpassing expectations, but reported a higher net loss of $0.57 per share compared to the forecast of $0.52. The stock saw a slight decline as profitability remains a challenge. The company is maintaining its full-year revenue guidance and is focusing on expanding in the US market and strengthening its sales team. » Mere på de.investing.com


  • CVRx receives continued Medicare reimbursement for Barostim but lowers revenue forecast

    The Centers for Medicare and Medicaid Services propose to continue reimbursing CVRx's Barostim implantation procedure at around $45,000. Despite this positive regulatory development, CVRx missed revenue expectations in the first quarter and lowered its annual forecast, citing sales challenges. Analysts downgraded the stock due to ongoing uncertainties and volatile revenues. » Mere på de.investing.com

Virksomhedstal

I det seneste år havde CVR Medical en omsætning på 0 € og et nettoresultat på -1,58 mio. €
(EUR) 2021
YoY
Omsætning 0 -
Bruttofortjeneste -215,45 7,54 %
Nettoresultat -1,58 mio. 1.012,76 %
EBITDA -602,63 t 1.587,74 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
976,31 €
Antal aktier
107,2 mio.
Højeste/laveste i 52 uger
0,0000091 € - 0,0000009 €
Udbytte Nej
Beta
1,82
P/E (PE Ratio)
0,00
PEG (PEG Ratio)
0,00
K/I (PB Ratio)
0,00
P/S (PS Ratio)
0,00

Virksomhedsprofil

CVR Medical Corp., et sundhedsselskab, forsker i og udvikler teknologi til analyse af subsoniske, infrasoniske og lavfrekvente lydbølger til sundhedssektoren. Selskabet leverer carotid stenotic scan-enheden, et diagnostisk værktøj til at opdage og måle stenose i halspulsåren. Det tilbyder sine produkter til patienter, betalere og sundhedsudbydere. CVR Medical Corp. blev stiftet i 1980 og har hovedkontor i North Vancouver, Canada.

Navn
CVR Medical
CEO
Darren Day
Hjemsted North Vancouver, bc
Canada
Websted
Børsnotering
02.11.2016
Medarbejdere 3

Tickersymboler

Børs Symbol
Pnk
CRRVF
London
0UMW.L
München
B3BN.MU
🍪

Parqet  bruger cookies. Læs mere